Affinity Asset Advisors »

Verastem shares owned by Affinity Asset Advisors

Quarter-by-quarter ownership of Verastem (VSTM) shares owned by Affinity Asset Advisors from 13F filings

Historical chart of Affinity Asset Advisors investment in Verastem

Tip: Access up to 7 years of quarterly data

All positions including Verastem held by Affinity Asset Advisors consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Verastem by Affinity Asset Advisors

Quarter filed Position value Share count Share price at filing
2024-09-30 $1.2M 400k 2.99

More positions owned by Affinity Asset Advisors

Xenon Pharmaceuticals (XENE)
Teva Pharmaceutical Inds Sponsored Ads (TEVA)
Cassava Sciences Put Option (SAVA)
Apogee Therapeutics (APGE)
Nuvalent Inc-a (NUVL)
Arcellx Common Stock (ACLX)
Alkermes SHS (ALKS)
Madrigal Pharmaceuticals (MDGL)
Crinetics Pharmaceuticals In (CRNX)
Nurix Therapeutics (NRIX)
Vera Therapeutics Cl A (VERA)
Verona Pharma Sponsored Ads (VRNA)
Autolus Therapeutics Spon Ads (AUTL)
Centessa Pharmaceuticals Sponsored Ads (CNTA)
Inozyme Pharma (INZY)

View all positions for Affinity Asset Advisors

Top funds holding Verastem

Nantahala Capital Management
OrbiMed Advisors
BlackRock
Alyeska Investment Group
BVF
Soleus Capital Management
BlackRock
Vanguard Group
Stonepine Capital Management
Geode Capital Management
Affinity Asset Advisors
State Street Corporation
Northern Trust
Tang Capital Management
Kennedy Capital Management

View all funds holding Verastem